Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Nixon Cox currently holds 7,189 shares of Alto Neuroscience, Inc. (ANRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Nixon Cox has been a net neutral trader of ANRO stock. They have purchased $0 and sold $0 worth of shares.
Christopher Nixon Cox's most recent insider trade was on Jan 2, 2026, when they sold 7,189 shares at $11.82 per share.
Christopher Nixon Cox serves as Executive at Alto Neuroscience, Inc. (ANRO). They have executed 7 insider transactions totaling $0 over their tenure at the company.
Christopher Nixon Cox holds the position of Executive at Alto Neuroscience, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Christopher Nixon Cox has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Christopher Nixon Cox was on Jan 2, 2026, when they purchased $85.0K worth of ANRO shares. This transaction involved 7,189 shares at $11.82 per share.
Christopher Nixon Cox currently owns 7,189 shares of Alto Neuroscience, Inc. (ANRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Nixon Cox's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Nixon Cox has 7 Form 4 filings on record as an insider at Alto Neuroscience, Inc..
Set alerts for Christopher Nixon Cox and 40,000+ other insiders.